Mirada Medical, a multi-modality cancer imaging specialist, and RefleXion Medical, a developer of radiation therapy equipment, are collaborating to explore the viability of RefleXion’s PET-guided radiotherapy system in fighting cancer.
The two companies will present an initial study demonstrating the integration of RefleXion’s novel approach with Mirada RTx at the American Association of Physicists in Medicine (AAPM) annual meeting in Austin, Tex. “Joint Imaging: Therapy Scientific Session, Treatment Response Assessment” will take place on Thursday, July 24th.
Mirada Medical previously developed software for PET analysis in the early 2000s and has remained engaged in the effort to integrate PET imaging into radiation therapy planning. The RefleXion system combines external beam radiation therapy and PET imaging to provide radiation to multiple targets. The partnership will further feasibility studies and proof-of-principle simulations to assess the potential of the RefleXion system with clinical positron emission tomography (PET) and CT imaging datasets.
“Mirada has a very strong track record working with both PET imaging, and imaging for radiation treatment planning,” said Hugh Bettesworth, CEO of Mirada Medical. “I am very excited to have this opportunity to partner with RefleXion and help establish a truly innovative approach to cancer radiotherapy.”